Edition:
India

People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

153.87USD
16 Oct 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$153.87
Open
$155.79
Day's High
$159.14
Day's Low
$150.82
Volume
287,140
Avg. Vol
330,472
52-wk High
$178.45
52-wk Low
$105.05

Doubleday, Richard 

Mr. Richard B. Doubleday serves as Executive Vice President, Chief Commercial Officer of DexCom Inc., since January 2015. From February 2013 to January 2015, Mr. Doubleday served as our Senior Vice President of Worldwide Sales and Marketing. From June 2009 to February 2013, Mr. Doubleday served as our Vice President of Sales. From May 1988 to June 2009, Mr. Doubleday served in various roles for Johnson & Johnson, Inc. (“J&J”), including Director of Marketing for J&J subsidiary Animas Corporation, a manufacturer of insulin pumps, from July 2006 to June 2009, and Field Sales Director for J&J subsidiary LifeScan, Inc., a manufacturer of blood glucose monitoring systems, from August 2002 to October 2005. Mr. Doubleday received a B.A. from Michigan State University.

Basic Compensation

Total Annual Compensation, USD 867,216
Restricted Stock Award, USD 2,317,820
Long-Term Incentive Plans, USD --
All Other, USD 22,422
Fiscal Year Total, USD 3,207,460

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Sayer

9,554,120

Quentin Blackford

3,391,640

Jake Leach

--

Donald Abbey

2,919,160

Andrew Balo

3,174,640

Richard Doubleday

3,207,460
As Of  31 Dec 2018